Medistat Ltd., Israel   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Tel Aviv Israel (1995)

Organization Overview

First Clinical Trial
2018
NCT03538951
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

MediStat Ltd. | Medistat Ltd., Israel

Active Ingredients

Drugs in Phase 4 Trials (1)

echinaforce (2 trials)

Drugs in Phase 3 Trials (1)

estradiol (progynon depot) (1 trial)

Drugs in Phase 2 Trials (1)

vda-1102 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 3)

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Psychotic Disorders (Phase 3)

Schizophrenia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 3